Genomic organization and chromosomal localization of the human CD27 gene.
暂无分享,去创建一个
[1] H. Stein,et al. Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease , 1992, Cell.
[2] G. Wong,et al. Molecular cloning and expression of a receptor for human tumor necrosis factor , 1990, Cell.
[3] H. Tabuchi,et al. Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor , 1990, Cell.
[4] R. V. van Lier,et al. Alternative molecular form of human T cell‐specific antigen CD27 expressed upon T cell activation , 1989, European journal of immunology.
[5] G. Crabtree. Contingent genetic regulatory events in T lymphocyte activation. , 1989, Science.
[6] A. E. Sippel,et al. Viral myb oncogene encodes a sequence-specific DNA-binding activity , 1988, Nature.
[7] M. Chao,et al. A constitutive promoter directs expression of the nerve growth factor receptor gene. , 1988, Molecular and cellular biology.
[8] P. Sharp,et al. Human CCAAT-binding proteins have heterologous subunits , 1988, Cell.
[9] D. Lipman,et al. Improved tools for biological sequence comparison. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[10] R. Levi‐montalcini,et al. The nerve growth factor 35 years later. , 1987, Science.
[11] C. Richardson,et al. DNA sequence analysis with a modified bacteriophage T7 DNA polymerase. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[12] P. Nowell,et al. Sequential expression of protooncogenes during lectin-stimulated mitogenesis of normal human lymphocytes. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[13] J. Devereux,et al. A comprehensive set of sequence analysis programs for the VAX , 1984, Nucleic Acids Res..
[14] A. F. Williams,et al. The immunoglobulin superfamily--domains for cell surface recognition. , 1988, Annual review of immunology.
[15] N. Murray. Phage Lambda and Molecular Cloning , 1983 .